BlackRock Fund Advisors’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$13.7M Buy
240,309
+34,727
+17% +$3.18M ﹤0.01% 2399
2016
Q3
$26.3M Buy
205,582
+13,279
+7% +$1.7M 0.01% 1938
2016
Q2
$24M Buy
192,303
+17,665
+10% +$2.03M 0.01% 1929
2016
Q1
$14.6M Buy
174,638
+8,169
+5% +$673K ﹤0.01% 2164
2015
Q4
$16.5M Buy
166,469
+5,890
+4% +$631K ﹤0.01% 2162
2015
Q3
$19.7M Sell
160,579
-965
-0.6% -$131K 0.01% 1999
2015
Q2
$24.8M Sell
161,544
-2,769
-2% -$457K 0.01% 1980
2015
Q1
$28M Buy
164,313
+2,575
+2% +$390K 0.01% 1876
2014
Q4
$24.7M Buy
161,738
+23,882
+17% +$2.98M 0.01% 1938
2014
Q3
$14.6M Sell
137,856
-3,300
-2% -$460K ﹤0.01% 2140
2014
Q2
$21.5M Sell
141,156
-18,464
-12% -$2.46M 0.01% 1977
2014
Q1
$20.5M Buy
159,620
+3,230
+2% +$502K 0.01% 1983
2013
Q4
$27.3M Sell
156,390
-36,664
-19% -$6.3M 0.01% 1799
2013
Q3
$31.2M Buy
193,054
+21,934
+13% +$3.45M 0.01% 1672
2013
Q2
$22.7M Buy
+171,120
New +$24.2M 0.01% 1767

Other funds holding ELGX

BlackRock Fund Advisors's ELGX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Endologix Inc (ELGX) stake by 17% in Q4 2016, buying an estimated $3.18M and bringing the position to 240,309 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

BlackRock Fund Advisors first reported a position in ELGX in Q2 2013 and has held it in 15 quarters since. The position peaked at $31.2M in Q3 2013. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • BlackRock Fund Advisors held 240,309 shares of Endologix Inc worth $13.7M as of Q4 2016.
  • BlackRock Fund Advisors bought 34,727 Endologix Inc shares in Q4 2016, an estimated $3.18M.
  • Endologix Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2399 holding.
  • BlackRock Fund Advisors first reported a position in Endologix Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Endologix Inc position peaked at $31.2M in Q3 2013.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.